The 2nd Paragraph IV Litigation Strategy Congress

The 2nd Paragraph IV Litigation Strategy Congress

Speaking Engagement

Featuring a completely updated speaker faculty for this year, the 2nd Paragraph IV Litigation Strategy Congress focuses on the underlying strategy that can often make or break a Paragraph IV dispute. Explore the most top of mind issues currently impacting pharmaceutical manufacturers on both sides including:

  • The Top 3 Pre-Suit Due Diligence Issues Counsel on Both Sides Should Be Evaluating In Anticipation of a Paragraph IV Suit
  • Recent Developments at the Intersection of FDA Regulatory and IP Law and How These Developments are Impacting Approaches to Paragraph IV Disputes
  • Forfeiture and Multiple Filers: Insights for Avoiding or Triggering Forfeiture Events in Hatch-Waxman Litigation Involving Multiple ANDA Filers
  • PTO v. Federal Court: Evaluating the Emerging Impact of Parallel PTO Proceedings on the Procedural Dynamics of Hatch Waxman District Litigation

WilmerHale Senior Counsel Arthur Gajarsa is a featured speaker on the panel "Key Takeaways for Brand and Generic Drug Manufacturers From Recent Case Law."

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.